Sensor-based congestion alert for peritoneal dialysis
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new sensor system that can predict fluid overload (congestion) in people on peritoneal dialysis. It may help you and your care team spot problems early so you can avoid hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You can stand on both bare feet without help (for a short time)
- You are using an automated peritoneal dialysis machine (a machine that does your dialysis at night)
- You are already being followed on the Vantive Sharesource remote monitoring platform
- You do not have a kidney transplant planned in the next year
- You are not pregnant or planning to become pregnant in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app called MiDiálisis designed to help people on peritoneal dialysis (home dialysis) track their treatment. It looks at whether the app is easy to use and helpful for staying on track.
This study uses a continuous glucose monitor to track blood sugar levels in people with diabetes who are on peritoneal dialysis. It may help improve diabetes management during dialysis.
This trial tests a remote monitoring system for people on automated peritoneal dialysis (APD) at home. It aims to see if this technology improves quality of life and mental health.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
This study tests a device that uses light to check the health of your AV access (the blood vessel connection used for dialysis) without touching it. It may help doctors spot problems early.
Hear when a new End Stage Kidney Disease (ESRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.